Oncosem Signs 5-Year Contract with Başakşehir Çam and Sakura City Hospital

Oncosem Onkolojik Sistemler has announced the signing of a five-year chemotherapy drug preparation service contract with Başakşehir Çam and Sakura City Hospital. This agreement is considered a significant step in the company's strategy to expand its service portfolio in the healthcare sector. Under the contract, the company will undertake the hospital's chemotherapy drug preparation processes, leveraging its expertise in oncology. This collaboration is expected to enhance the hospital's capacity to manage patient volume while providing Oncosem with a steady revenue stream. Company officials have expressed expectations that the new business relationship will have a positive impact on revenue and profitability. This service agreement, which will last for five years, stands out as a strategic partnership projected to make a stable contribution to the company's financial performance. This development is seen as a step taken in line with Oncosem's goal of establishing long-term collaborations with healthcare institutions. The company is expected to strengthen its operational capacity and market position in the oncology field. This is not investment advice.